Template:BNP value/es: Difference between revisions

(Created page with "===Péptido natriurético cerebral (BNP)<ref>Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. doi:10.1056/NEJMoa020233.</ref>===")
 
(Created page with "===NT-proBNP<ref>Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb. 27(3):330-7.</ref><ref>Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in...")
 
Line 3: Line 3:
===[[Special:MyLanguage/Brain natriuretic peptide (BNP)|Péptido natriurético cerebral (BNP)]]<ref>Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. doi:10.1056/NEJMoa020233.</ref>===
===[[Special:MyLanguage/Brain natriuretic peptide (BNP)|Péptido natriurético cerebral (BNP)]]<ref>Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. doi:10.1056/NEJMoa020233.</ref>===


<div lang="en" dir="ltr" class="mw-content-ltr">
*Medición
*Measurement
**'''<100 pg/mL''': Negativa para insuficiencia cardíaca aguda (Sn 90%, VPN 89%)
**'''<100 pg/mL''': Negative for acute CHF (Sn 90%, NPV 89%)
**'''100-500 pg/mL''': Indeterminada (Considerar diagnóstico diferencial y probabilidad pre-prueba)
**'''100-500 pg/mL''': Indeterminate (Consider differential diagnosis and pre-test probability)
**'''>500 pg/mL''': Positiva para insuficiencia cardíaca aguda (Sp 87%, VPP 90%)
**'''>500 pg/mL''': Positive for acute CHF (Sp 87%, PPV 90%)
**Combinación de BNP con juicio clínico 94% sensible 70% específico (comparado con 49% sn y 96% spec juicio clínico solo) <ref> McCullough et al. B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 2002:DOI: 10.1161/01.CIR.0000025242.79963.4</ref>
**Combination of BNP with clinician judgment 94% sensitive 70% specific (compared to 49% sn and 96% spec clinical judgement alone) <ref> McCullough et al. B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 2002:DOI: 10.1161/01.CIR.0000025242.79963.4</ref>
</div>




<div lang="en" dir="ltr" class="mw-content-ltr">
===[[Special:MyLanguage/NT-proBNP|NT-proBNP]]<ref>Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb. 27(3):330-7.</ref><ref>Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005 Feb 17. 352(7):666-75.</ref><ref>Moe GW, Howlett J, Januzzi JL, Zowall H,. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007 Jun 19. 115(24):3103-10.</ref>===
===[[Special:MyLanguage/NT-proBNP|NT-proBNP]]<ref>Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb. 27(3):330-7.</ref><ref>Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005 Feb 17. 352(7):666-75.</ref><ref>Moe GW, Howlett J, Januzzi JL, Zowall H,. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007 Jun 19. 115(24):3103-10.</ref>===
</div>


<div lang="en" dir="ltr" class="mw-content-ltr">
*<300 pg/mL → [[Special:MyLanguage/CHF|Insuficiencia cardíaca]] improbable
*<300 pg/mL → [[Special:MyLanguage/CHF|CHF]] unlikely
*[[Special:MyLanguage/CHF|Insuficiencia cardíaca]] probable en:
*[[Special:MyLanguage/CHF|CHF]] likely in:
**'''>450 pg/mL''' en edad < 50 años
**'''>450 pg/mL''' in age < 50 years old
**'''>900 pg/mL''' en 50-75 años
**'''>900 pg/mL''' in 50-75 years old
**'''>1800 pg/mL''' en > 75 años
**'''>1800 pg/mL''' in > 75 years old
</div>

Latest revision as of 00:59, 26 January 2026

Other languages:

Péptido natriurético cerebral (BNP)[1]

  • Medición
    • <100 pg/mL: Negativa para insuficiencia cardíaca aguda (Sn 90%, VPN 89%)
    • 100-500 pg/mL: Indeterminada (Considerar diagnóstico diferencial y probabilidad pre-prueba)
    • >500 pg/mL: Positiva para insuficiencia cardíaca aguda (Sp 87%, VPP 90%)
    • Combinación de BNP con juicio clínico 94% sensible 70% específico (comparado con 49% sn y 96% spec juicio clínico solo) [2]


NT-proBNP[3][4][5]

  1. ↑ Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. doi:10.1056/NEJMoa020233.
  2. ↑ McCullough et al. B-Type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation. 2002:DOI: 10.1161/01.CIR.0000025242.79963.4
  3. ↑ Januzzi JL, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J. 2006 Feb. 27(3):330-7.
  4. ↑ Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005 Feb 17. 352(7):666-75.
  5. ↑ Moe GW, Howlett J, Januzzi JL, Zowall H,. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation. 2007 Jun 19. 115(24):3103-10.
Retrieved from "https://www.wikem.org/w/index.php?title=Template:BNP_value/es&oldid=384204"